MONTREAL, May 08, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:GUD) (“Knight” or the “Corporation”) a leading pan-American (ex-US) specialty […]
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) — Birchtree Investments Ltd. (“Birchtree” or the “Company”) (CSE: BRCH), an investment […]
CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel […]